Guidelines for Breast MRI Eligibility
Guidelines for Breast MRI Eligibility
MRI indicated at diagnosis:
- in a woman with newly diagnosed breast cancer, at risk of multifocality, to assess the need for mastectomy or lumpectomy;
- in a woman with an occult breast cancer diagnosed with only axillary adenopathy. The breast cancer is occult on mammography, ultrasound, or physical exam;
- in a woman receiving neoadjuvant chemotherapy, to assess both at diagnosis, and at the post chemotherapy, preoperative period for disease extent;
- in a woman with a posteriorly placed tumor to determine pectoralis muscle involvement;
- in a woman who has an MRI-detected lesion who has no evidence of it on mammogram, ultrasound, or physical exam. An MRI in follow up is allowed at six months following benign pathology on a biopsy of that site to ensure that the site was assessed or at a shorter interval if the pathologic findings are considered discordant with the MRI appearance of the lesion;
- in a woman six months after a previous MRI with BI-RADS Category 3 findings;
- for the presence of pathologic nipple discharge when mammography, ultrasound, and ductography either cannot be performed or the results are equivocal or negative.
MRI eligible every two years:
- in a woman who has undergone a mastectomy and a reconstruction with an implant;
- in a woman with radiographically dense breasts and a breast cancer history;
- in a woman who is premenopausal with dense breasts and a personal history of cellular atypia, lobular carcimoma in situ, breast cancer, or a single first-degree relative with premenopausal breast cancer;
MRI eligible every year:
- in a woman who has the confirmed presence of a BRCA1 or BRCA2 gene mutation or other syndrome that has a high incidence of breast cancer such as Li-Fraumaeni, Cowden, or Bannayan-Riley-Ruvalcaba. Also included are patients with a greater than 20% lifetime risk of breast cancer as defined by published, validated models that are mainly defined by family history;
- in a woman who has a high likelihood of having a BRCA mutation because of: three or more first degree relatives on the same side of the family, regardless of age at diagnosis with breast cancer; fewer than three relatives who were diagnosed at less than 45 years old; a family member detected with a BRCA mutation; one or more family members with ovarian cancer and one or more members with breast cancer, both on the same side of the family; there are multiple breast cancers in one family member; male breast cancer in a family member; the woman is a member of an ethnic group at high risk for breast cancer (Ashkenazi Jewish descent) and one family member with breast or ovarian cancer; or the presence of Li-Fraumaeni, Cowden, or Bannayan-Riley-Ruvalcaba in a first-degree relative;
- in a woman with a history of chest radiation between the ages of 10 and 30.
Source: Rutland (VT) Regional Medical Center, adopted from the Vermont Blue Cross Blue Shield Guidelines.
MRI indicated at diagnosis: in a woman with newly diagnosed breast cancer, at risk of multifocality, to assess the need for mastectomy or lumpectomy;Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.